Document Type

Original Article


Background: Diabetes has become an important risk factor for major morbidity and death, hospitalizations, disease severity, acute renal failure, acute respiratory distress syndrome, ICU admissions and patient death. with coronavirus disease 2019. Aim: To study glycemic changes and outcomes in diabetic and non-diabetic patients hospitalized with COVID-19. Patients and Methods: In this retrospective study, 500 hospitalized adult patients over 18 years of age with COVID-19 were referred to Al-Azhar – Assiut and Chest – Assiut University Hospitals with nasopharyngeal vaccination against SARS-CoV-2. Our study spanned approximately seven months of confirmed COVID-19 from January 2021 to July 2021. Results: Patients with COVID-19 were divided into two groups based on their glycemic status: DM-COVID group: 217 patients were included. There was no statistically significant difference between the two groups in terms of age (p > 0.05). The significant difference between the COVID-with-DM group and the COVID-without-DM group in terms of hypertension, hemoglobin levels, chest area, random blood glucose measurements, need for ICU and need for mechanical ventilation was significantly greater in DM-COVID - 19 group. The COVID group without DM measured mortality (p


COVID-19; Glucose; Diabetes Mellitus; Glycemic

Subject Area

Internal Medicine